Abstract |
Colon cancer liver metastasis is often the lethal aspect of this disease. Well-isolated metastases are candidates for surgical resection, but recurrence is common. Better adjuvant treatment is therefore needed to reduce or prevent recurrence. In the present study, HT-29 human colon cancer cells expressing red fluorescent protein (RFP) were used to establish liver metastases in nude mice. Mice with a single liver metastasis were randomized into bright-light surgery (BLS) or the combination of BLS and adjuvant treatment with tumor-targeting S. typhimurium A1-R. Residual tumor fluorescence after BLS was clearly visualized at high magnification by fluorescence imaging. Adjuvant treatment with S. typhimurium A1-R was highly effective to increase survival and disease-free survival after BLS of liver metastasis. The results suggest the future clinical potential of adjuvant S. typhimurium A1-R treatment after liver metastasis resection.
|
Authors | Takashi Murakami, Yukihiko Hiroshima, Ming Zhao, Yong Zhang, Takashi Chishima, Kuniya Tanaka, Michael Bouvet, Itaru Endo, Robert M Hoffman |
Journal | Oncotarget
(Oncotarget)
Vol. 6
Issue 39
Pg. 41856-62
(Dec 08 2015)
ISSN: 1949-2553 [Electronic] United States |
PMID | 26497690
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Luminescent Proteins
- red fluorescent protein
- Green Fluorescent Proteins
|
Topics |
- Animals
- Biological Therapy
(methods)
- Colonic Neoplasms
(genetics, metabolism, pathology)
- Combined Modality Therapy
- Green Fluorescent Proteins
(biosynthesis, genetics)
- HT29 Cells
- Hepatectomy
- Humans
- Liver Neoplasms
(genetics, metabolism, microbiology, secondary, therapy)
- Luminescent Proteins
(biosynthesis, genetics)
- Mice, Nude
- Neoplasm Recurrence, Local
(prevention & control)
- Salmonella typhimurium
(genetics, growth & development, metabolism, pathogenicity)
- Time Factors
- Transfection
- Xenograft Model Antitumor Assays
|